Abstract: Poster Presentations |

Similar Outcomes With the Use of Extended Donors in Lung Transplantation FREE TO VIEW

Deborah Levine, MD; Luis F. Angel, MD, FCCP; Edward Sako, MD; Scott Johnson, MD; John Calhoon, MD; Stephanie M. Levine, MD, FCCP
Author and Funding Information

Univ. of Texas Health Science Center, San Antonio, TX


Chest. 2003;124(4_MeetingAbstracts):202S. doi:10.1378/chest.124.4_MeetingAbstracts.202S
Text Size: A A A
Published online


PURPOSE:  The primary limiting factor to lung transplantation is the shortage of donor lungs. A number of single center studies have suggested that the use of extended donor criteria may improve the donor supply and decrease waiting times without compromising outcomes. Despite these encouraging results, the use of extended donors is still a controversial issue. We report our center’s outcomes using extended vs. standard donor.

METHODS:  We reviewed records of lung donors selected for transplant at UTHSCSA from 9/26/02 to 4/30/03 characterizing them as an extended (group I) vs. standard donor (Group II). Donors were considered extended if any of the following criteria were met: Age > 55 years, smoking > 20 pack years, PaO2/Fi02 ratio <300, CXR infiltrate, purulent secretions on bronchoscopy or history of pulmonary disease. We then reviewed the early outcomes and spirometry of each recipient to evaluate potential consequences of using extended donor lungs. Outcomes evaluated were total length of stay (LOS), ICU LOS, length of intubation, 30-day mortality, and FEV1 (6 and 12 months) post-transplant.

RESULTS:  Both groups had similar pre-transplant diagnoses and transplant type.

CONCLUSION:  Our center’s results are similar to those of other studies showing that outcomes were no different when using extended vs. standard donors. This has allowed us to decrease the waiting time in our program considerably without compromising outcomes of the recipients.IMPLICATIONS: Because the supply of donor lungs is so limited, it is important to create new standardized donor criteria, which reflect the current experience of and clinical practice at some lung transplant centers. Moreover, the results of using extended donor criteria should be incorporated into a national database so that the clinical outcomes could be evaluated in a multi-center prospective manner. Group 1*Group II*p valueNumber of patients2011Waiting time64 +/− 2542 +/− 130.08Total LOS11.5 +/− 49 +/− 1.480.065ICU LOS4 +/− 2.73 +/− 0.890.08Length of intubation2 +/− 2.761 +/− 0.530.17Re-Admissions1.0 +/− 0.360.5 +/− 0.370.27FEV1 (6 months)1.64 +/− 0.11.99 +/− 0.60.29FEV1 (12 months)1.74 +/− 0.242.35 +/− 0.30.2130 day mortality00* Results are median +/− Standard Error

DISCLOSURE:  D. Levine, None.

Wednesday, October 29, 2003

12:30 PM - 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543